Vivani Medical (VANI) Receivables (2014 - 2026)

Vivani Medical (VANI) posted quarterly Receivables of $12000.0 for Q1 2026, down 97.36% quarter-over-quarter from $455000.0 in Q4 2019.

Vivani Medical (VANI) Receivables (2014 - 2026) Analysis & Trends

Vivani Medical's Receivables history runs 7 years deep, the most recent figure standing at $12000.0 for Q1 2026.

In Q1 2026, Receivables changed N/A year-over-year to $12000.0; the TTM figure through Mar 2026 stood at $12000.0 (changed N/A YoY), while the FY2019 annual figure was $455000.0, down 9.72% from the prior year.
Receivables for Q1 2026 stood at $12000.0, down from $455000.0 in the prior quarter.
The five-year high for Receivables was $12000.0 in Q1 2026, with the low at $12000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	2.13 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	6.57 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.93 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	160.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	1.06 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	912.74 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.09 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	215.33 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Vivani Medical	120.18 Mn	100.29 Mn	-	-

Download Data